STAT4 gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Chinese Guangxi

Shurong Lu1, Huan Zhong1, Fugang Liu1

  • 1The Second Affiliated Hospital of Guangxi Medical University, Department of Nephrology, Nanning, Guangxi 530021, China.

Human Immunology
|January 25, 2025
PubMed
Abstract

Insights

The STAT4 gene rs7574865 polymorphism is linked to an increased risk of microscopic polyangiitis (MPA) in the Chinese Guangxi population. This finding suggests STAT4 genetic variations contribute to MPA susceptibility and disease classification.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Microscopic polyangiitis (MPA) is a severe autoimmune disease with a known genetic component.
  • The role of the STAT4 gene in MPA development remains unclear.

Purpose of the Study:

  • To investigate the association between STAT4 gene polymorphisms (rs7572482, rs7574865, rs12991409) and MPA susceptibility in the Guangxi population of China.

Main Methods:

  • Propensity score matching (PSM) was used to create matched case-control groups.
  • High-throughput sequencing and multiplex PCR identified STAT4 single nucleotide polymorphisms (SNPs).
  • Statistical analyses evaluated allele/genotype frequencies, linkage disequilibrium, haplotypes, and SNP-SNP interactions using SHEsis, SNPstats, and GMDR.

Main Results:

  • The rs7574865 polymorphism showed significant differences in allele and genotype frequencies between MPA patients and controls.
  • Haplotypes GGT and GTT were associated with reduced and increased MPA risk, respectively.
  • Rs7574865 polymorphism significantly increased MPA risk across multiple genetic models, particularly in Han Chinese males. STAT4 rs7574865 and PTPN22 rs3811021 formed a high-risk combination. STAT4 polymorphisms correlated with renal pathology, BVAS, and ALT levels.

Conclusions:

  • STAT4 gene polymorphisms are associated with MPA susceptibility and renal pathology in the Chinese Guangxi population.
  • The T allele of rs7574865 is identified as a significant risk factor for MPA.